NBIX icon

Neurocrine Biosciences
NBIX

Overview Fund Activity

133 hedge funds and large institutions have $1.68B invested in Neurocrine Biosciences in 2014 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 44 increasing their positions, 46 reducing their positions, and 22 closing their positions.

Holders
133
Holders Change
–
Holders Change %
0%
% of All Funds
3.55%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
25
Increased
44
Reduced
46
Closed
22
Calls
$17.4M
Puts
$52.4M
Net Calls
-$35.1M
Net Calls Change
-$37.4M

Top Buyers

1
Jennison Associates
1
Jennison Associates
New York
$19.7M
2
Millennium Management
2
Millennium Management
New York
$27.3M
3
PC
3
PointState Capital
New York
$16.8M
4
VAM
4
Visium Asset Management
New York
$55M
5
CCI
5
Columbus Circle Investors
$12.6M

Top Sellers

1
ACM
1
Americafirst Capital Management
California
$0
2
PA
2
Perceptive Advisors
New York
$79.6M
3
GPP
3
Great Point Partners
Connecticut
$0
4
Loomis, Sayles & Company
4
Loomis, Sayles & Company
Massachusetts
$10.6M
5
TCM
5
Tekla Capital Management
Massachusetts
$22.3M
Name Holding Trade Value Shares
Change 		Shares
Change %
Thrivent Financial for Lutherans
26
Thrivent Financial for Lutherans
Minnesota
$14.4M -$238K -10,650 -2%
FAM
27
Fred Alger Management
New York
$14M +$670K +29,981 +5%
CCI
28
Columbus Circle Investors
$12.6M +$12.1M +543,066 +2,384%
BBA
29
Baker Bros. Advisors
New York
$12.4M – – –
EA
30
Emerald Advisers
Pennsylvania
$12.1M +$4.62M +206,790 +62%
Loomis, Sayles & Company
31
Loomis, Sayles & Company
Massachusetts
$10.6M -$12.5M -558,519 -54%
Allianz Asset Management
32
Allianz Asset Management
Germany
$10.3M +$4.58M +205,210 +80%
EMFAT
33
Emerald Mutual Fund Advisers Trust
Pennsylvania
$10.2M +$3.37M +150,948 +50%
Geode Capital Management
34
Geode Capital Management
Massachusetts
$9.52M +$235K +10,535 +3%
Goldman Sachs
35
Goldman Sachs
New York
$9.24M -$4.55M -203,819 -33%
Bank of New York Mellon
36
Bank of New York Mellon
New York
$8.67M -$28.6K -1,280 -0.3%
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$8.25M +$1.64M +73,568 +25%
RSCM
38
Rock Springs Capital Management
Maryland
$8.04M +$1.01M +45,000 +14%
Axa
39
Axa
France
$7.64M -$395K -17,682 -5%
TCIM
40
TIAA CREF Investment Management
New York
$6M -$738K -33,034 -11%
BIM
41
BlackRock Investment Management
Delaware
$5.77M -$101K -4,526 -2%
CS
42
Credit Suisse
Switzerland
$5.66M +$565K +25,284 +11%
First Manhattan
43
First Manhattan
New York
$5.43M – – –
AAMU
44
Amundi Asset Management US
Massachusetts
$5.33M -$5.93M -265,317 -53%
Lord, Abbett & Co
45
Lord, Abbett & Co
New Jersey
$5.23M -$1.96M -87,921 -27%
Asset Management One
46
Asset Management One
Japan
$4.97M +$1.5M +66,890 +43%
BG
47
BlackRock Group
United Kingdom
$4.92M -$478K -21,386 -9%
TD Asset Management
48
TD Asset Management
Ontario, Canada
$4.74M +$311K +13,900 +7%
Charles Schwab
49
Charles Schwab
California
$4.72M +$155K +6,946 +3%
California Public Employees Retirement System
50
California Public Employees Retirement System
California
$4.71M +$1.24M +36,900 +36%
1
2
3 4 5